TENAX THERAPEUTICS, INC. Impairment of Long-Lived Assets to be Disposed of
TENAX THERAPEUTICS, INC. (TENX) reported Impairment of Long-Lived Assets to be Disposed of of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-04-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf · last filed 2018-04-02
- TENAX THERAPEUTICS, INC. impairment of long-lived assets to be disposed of for the quarter ending 2016-12-31 was $33.27M.
- TENAX THERAPEUTICS, INC. impairment of long-lived assets to be disposed of for the quarter ending 2016-09-30 was $0.00.
- TENAX THERAPEUTICS, INC. impairment of long-lived assets to be disposed of for the quarter ending 2015-09-30 was $0.00.
- TENAX THERAPEUTICS, INC. impairment of long-lived assets to be disposed of for the quarter ending 2014-04-30 was $0.00, a 100.00% decline year-over-year.
- TENAX THERAPEUTICS, INC. impairment of long-lived assets to be disposed of for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- TENAX THERAPEUTICS, INC. impairment of long-lived assets to be disposed of for fiscal 2016 was $33.27M.
- TENAX THERAPEUTICS, INC. impairment of long-lived assets to be disposed of for fiscal 2015 was $1.03M.
- TENAX THERAPEUTICS, INC. impairment of long-lived assets to be disposed of for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
| Period end | Impairment of Long-Lived Assets to be Disposed of 3 month | Impairment of Long-Lived Assets to be Disposed of 6 month | Impairment of Long-Lived Assets to be Disposed of 8 month | Impairment of Long-Lived Assets to be Disposed of 9 month | Impairment of Long-Lived Assets to be Disposed of 12 month | Impairment of Long-Lived Assets to be Disposed of 12 month as first filed | Impairment of Long-Lived Assets to be Disposed of 530 month | Impairment of Long-Lived Assets to be Disposed of 533 month | Impairment of Long-Lived Assets to be Disposed of 536 month | Impairment of Long-Lived Assets to be Disposed of 539 month | Impairment of Long-Lived Assets to be Disposed of 542 month | Impairment of Long-Lived Assets to be Disposed of 545 month | Impairment of Long-Lived Assets to be Disposed of 554 month | Impairment of Long-Lived Assets to be Disposed of 557 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-04-02 | |||||||||||||
| 2016-12-31 | $33.27M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $33.27M derived: sum of 2 quarters · filed 2018-04-02 | $33.27M 10-K · filed 2018-04-02 | |||||||||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $0.00 10-Q · filed 2016-11-09 | ||||||||||||
| 2016-06-30 | $0.00 10-Q · filed 2016-08-09 | |||||||||||||
| 2015-12-31 | $0.00 10-K · filed 2017-03-16 | |||||||||||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.08M 10-Q · filed 2016-11-09 | ||||||||||||
| 2015-06-30 | $1.08M 10-Q · filed 2016-08-09 | |||||||||||||
| 2015-04-30 | $1.03M 10-K · filed 2017-03-16 | |||||||||||||
| 2014-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $0.00 derived: sum of 2 quarters · filed 2017-03-16 | $0.00 10-K · filed 2017-03-16 | $2.52K 10-K · filed 2014-07-29 | ||||||||||
| 2014-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | $0.00 10-Q · filed 2014-03-17 | $826.85K 10-Q · filed 2014-03-17 | |||||||||||
| 2013-10-31 | $0.00 10-Q · filed 2013-12-17 | $826.85K 10-Q · filed 2013-12-17 | ||||||||||||
| 2013-07-31 | $826.85K 10-Q · filed 2013-09-17 | |||||||||||||
| 2013-04-30 | $24.11K derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-29 | $24.11K derived: sum of 2 quarters · filed 2014-07-29 | $35.67K 10-K · filed 2014-07-29 | $826.85K 10-K · filed 2013-06-26 | ||||||||||
| 2013-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | $11.56K 10-Q · filed 2014-03-17 | $802.74K 10-Q · filed 2013-03-18 | |||||||||||
| 2012-10-31 | $11.56K 10-Q · filed 2013-12-17 | $802.74K 10-Q · filed 2012-12-14 | ||||||||||||
| 2012-07-31 | $791.17K 10-Q · filed 2012-09-19 | |||||||||||||
| 2012-04-30 | $27.76K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-26 | $120.85K derived: sum of 2 quarters · filed 2013-06-26 | $123.52K derived: sum of 3 quarters · filed 2013-06-26 | $123.52K 10-K · filed 2013-06-26 | $791.17K 10-K · filed 2012-07-25 | |||||||||
| 2012-01-31 | $93.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-18 | $95.76K derived: sum of 2 quarters · filed 2013-03-18 | $95.76K 10-Q · filed 2013-03-18 | $397.80K derived: sum of 4 quarters · filed 2013-03-18 | $763.41K 10-Q · filed 2012-03-15 | |||||||||
| 2011-10-31 | $2.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-14 | $2.67K 10-Q · filed 2012-12-14 | $304.71K derived: sum of 3 quarters · filed 2012-12-14 | $304.71K derived: sum of 4 quarters · filed 2012-12-14 | $670.33K 10-Q · filed 2011-12-15 | |||||||||
| 2011-07-31 | $0.00 10-Q · filed 2011-09-19 | $302.04K derived: sum of 2 quarters · filed 2012-07-25 | $302.04K derived: sum of 3 quarters · filed 2012-07-25 | $302.04K derived: sum of 4 quarters · filed 2012-07-25 | $667.65K 10-Q · filed 2011-09-19 | |||||||||
| 2011-04-30 | $302.04K derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-25 | $302.04K derived: sum of 2 quarters · filed 2012-07-25 | $302.04K derived: sum of 3 quarters · filed 2012-07-25 | $302.04K 10-K · filed 2012-07-25 | ||||||||||
| 2011-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-15 | $0.00 derived: sum of 2 quarters · filed 2012-03-15 | $0.00 10-Q · filed 2012-03-15 | |||||||||||
| 2010-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-15 | $0.00 10-Q · filed 2011-12-15 | ||||||||||||
| 2010-07-31 | $0.00 10-Q · filed 2011-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |